Source: Registered Drug Product Database (NG) Publisher: Me Cure Industries Limited, Plot 6 Block H Debo Industries Compound, Oshodi Industrial Scheme, Oshodi, Lagos, Nigeria
Albendazole is a benzimidazole carbamate with anthelmintic and antiprotozoal activity against intestinal and tissue parasites. Animal studies have shown that albendazole exhibits vermicidal, ovacidal and larvacidal activity and exerts its anthelmintic effect by inhibiting tubulin polymerization. This causes the disruption of the helminth metabolism, including energy depletion, which immobilises and then kills the susceptible helminth.
In man, after oral administration, albendazole is absorbed and completely metabolised. At a dose of 6,6 mg/kg of albendazole the plasma concentration of its main metabolite, the sulfoxide, attains a maximum of 0,25 to 0,30 μg/ml after approximately 2½ hours.
The half-life of the sulfoxide in the plasma is 8½ hours. The metabolite is essentially eliminated via the urine.
As a well-established and widely used product, the pre-clinical safety of ibuprofen is well documented.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.